Choreo LLC increased its stake in FactSet Research Systems Inc. (NYSE:FDS – Free Report) by 12.0% in the fourth quarter, ...

Moderna is now expecting 2025 research and development costs of about $4.1 billion and selling, general and administrative costs of about $1.1 billion. Cost of sales is expected to come to about $1.2 ...

Bio-Rad Laboratories' cost-cutting plans come as the company swung to a loss in the fourth quarter amid lower sales across its life-science segment. The company posted a net loss of $715.8 million, or ...

A gauge of the U.S. equities that equally weights stocks in the S&P 500 index was clinging to a slight gain on Friday afternoon. The Invesco S&P 500 Equal Weight ETF was up 0.1% in afternoon trading, ...

The persistent rise in US equities is helping promote a view that the relationships of old for stocks and traditional measures for value-oriented investing strategies no longer apply.

Dexcom stock stock recovered Friday after the diabetes devices maker missed fourth-quarter profit expectations.

Informatica shares are down 49% in the last 12 months, compared with the S&P 500 index's SPX gain of 22.4%. Shares of rival International Business Machines Corp. (IBM) are up 39.3% in the last 12 ...

Builders have increasingly relied on buyer incentives to mitigate the impact of higher borrowing costs on home shoppers as the average rate on a 30-year mortgage more than doubled in recent years from ...

The dollar is expected to reach its peak for the year in the first quarter, according to Bank of America’s latest forex and rates sentiment survey.

Following a strong quarter leading up to the holidays, Wall Street analysts are anticipating Arkansas-based Walmart to post fourth-quarter earnings of 65 cents per share on $180 billion in sales.

Doximity has been a top-rated stock at MAPsignals. That means the stock has unusual buy pressure and growing fundamentals. We ...